We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTW icon
1126
Willis Towers Watson
WTW
$28.6B
$2.39M ﹤0.01%
9,772
+2,610
+36% +$596K
TT icon
1127
Trane Technologies
TT
$107B
$2.38M ﹤0.01%
14,181
+1,051
+8% +$174K
IBN icon
1128
ICICI Bank
IBN
$107B
$2.38M ﹤0.01%
108,477
+65,155
+150% +$1.45M
PLYM
1129
DELISTED
Plymouth Industrial REIT
PLYM
$2.37M ﹤0.01%
123,638
+681
+0.6% +$12.9K
DAWN
1130
DELISTED
Day One Biopharmaceuticals
DAWN
$2.37M ﹤0.01%
110,000
LPLA icon
1131
LPL Financial
LPLA
$26.5B
$2.35M ﹤0.01%
10,886
+2,064
+23% +$482K
KSI
1132
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$2.35M ﹤0.01%
234,150
DVA icon
1133
DaVita
DVA
$15.2B
$2.34M ﹤0.01%
31,401
+2,981
+10% +$232K
TBPH icon
1134
Theravance Biopharma
TBPH
$874M
$2.34M ﹤0.01%
208,783
-5,296
-2% -$55.7K
SEM
1135
DELISTED
Select Medical
SEM
$2.34M ﹤0.01%
174,789
-3,168,171
-95% -$41M
GLNG icon
1136
Golar LNG
GLNG
$4.99B
$2.33M ﹤0.01%
102,196
-11,690
-10% -$293K
ABNB icon
1137
Airbnb
ABNB
$87.2B
$2.33M ﹤0.01%
27,216
-44
-0.2% -$4.44K
SPXC icon
1138
SPX Corp
SPXC
$11B
$2.31M ﹤0.01%
35,231
-21,186
-38% -$1.39M
ALSN icon
1139
Allison Transmission
ALSN
$10.1B
$2.31M ﹤0.01%
55,500
-1,242
-2% -$51K
WFC.PRL icon
1140
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
$2.31M ﹤0.01%
1,948
GEF icon
1141
Greif
GEF
$4.56B
$2.31M ﹤0.01%
34,400
ICFI icon
1142
ICF International
ICFI
$1.45B
$2.3M ﹤0.01%
23,261
-10,394
-31% -$1.13M
PRQR icon
1143
ProQR Therapeutics
PRQR
$244M
$2.29M ﹤0.01%
620,000
CL icon
1144
Colgate-Palmolive
CL
$73.6B
$2.27M ﹤0.01%
28,871
-17,406
-38% -$1.3M
OFG icon
1145
OFG Bancorp
OFG
$2.21B
$2.23M ﹤0.01%
80,900
+11,700
+17% +$321K
XLV icon
1146
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$2.23M ﹤0.01%
16,382
H icon
1147
Hyatt Hotels
H
$18B
$2.21M ﹤0.01%
24,469
-7,153
-23% -$657K
HAE icon
1148
Haemonetics
HAE
$3.63B
$2.18M ﹤0.01%
27,748
-12,852
-32% -$1.03M
NTNX icon
1149
Nutanix
NTNX
$15.4B
$2.17M ﹤0.01%
83,112
-28,462
-26% -$777K
VMW
1150
DELISTED
VMware, Inc
VMW
$2.16M ﹤0.01%
17,617
+3,901
+28% +$450K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.